Chemoinformaics analysis of FURAN-2-YLMETHYL HEXANOATE
Molecular Weight | 196.246 | nRot | 6 |
Heavy Atom Molecular Weight | 180.118 | nRig | 1 |
Exact Molecular Weight | 196.11 | nRing | 1 |
Solubility: LogS | -1.312 | nHRing | 1 |
Solubility: LogP | 1.637 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
nHA | 3 | APOL | 31.4447 |
nHD | 0 | BPOL | 20.3913 |
QED | 0.507 |
Synth | 1.758 |
Natural Product Likeliness | 0.132 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.152 |
MDCK | 0.0000359 |
BBB | 0.991 |
PPB | 0.331 |
VDSS | 1.084 |
FU | 0.798415 |
CYP1A2-inh | 0.856 |
CYP1A2-sub | 0.666 |
CYP2c19-inh | 0.219 |
CYP2c19-sub | 0.872 |
CYP2c9-inh | 0.032 |
CYP2c9-sub | 0.24 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.388 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.326 |
CL | 7.757 |
T12 | 0.774 |
hERG | 0.019 |
Ames | 0.017 |
ROA | 0.031 |
SkinSen | 0.19 |
Carcinogencity | 0.084 |
EI | 0.987 |
Respiratory | 0.134 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.698398 |